Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2021 from OUS - Rheumatology Research Group

25 publications found

Bianchi M, Kozyrev SV, Notarnicola A, Hultin Rosenberg L, Karlsson Å, Pucholt P, Rothwell S, Alexsson A, Sandling JK, Andersson H, Cooper RG, Padyukov L, Tjärnlund A, Dastmalchi M, ImmunoArray Development Consortium, The DISSECT consortium, Meadows JRS, Pyndt Diederichsen L, Molberg Ø, Chinoy H, Lamb J, Rönnblom L, Lindblad-Toh K, Lundberg IE (2021)
Contribution of rare genetic variation to disease susceptibility in a large Scandinavian myositis cohort
Arthritis Rheumatol (in press)
DOI 10.1002/art.41929, PubMed 34279065

Buschulte K, Hoffmann-Vold AM, Dobrota RD, Höger P, Krause A, Kreuter M (2021)
[Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]
Z Rheumatol, 80 (8), 743-754
DOI 10.1007/s00393-021-01067-3, PubMed 34505934

Didriksen H, Molberg Ø, Fretheim H, Gude E, Jordan S, Brunborg C, Palchevskiy V, Garen T, Midtvedt Ø, Andreassen AK, Distler O, Belperio J, Hoffmann-Vold AM (2021)
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol, 73 (7), 1277-1287
DOI 10.1002/art.41665, PubMed 33497027

Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen AC, Karsdal MA, Herrick AL, Distler JHW, Allanore Y, Hoffmann-Vold AM, Siebuhr AS, Distler O (2021)
Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study
Lancet Rheumatol., 3 (3), E175-E184
DOI 10.1016/S2665-9913(20)30385-4

Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM, SENSCIS trial investigators (2021)
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Lancet Respir Med, 9 (1), 96-106
DOI 10.1016/S2213-2600(20)30330-1, PubMed 33412120

Hoffmann-Vold AM, Bendstrup E, Dimitroulas T, Hesselstrand R, Morais A, Peltomaa R, Smith V, Welling J, Vonk MC, Wuyts WA (2021)
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keab154, PubMed 33587103

Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø (2021)
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
BMJ Open, 11 (6), e048541
DOI 10.1136/bmjopen-2020-048541, PubMed 34168032

Hoffmann-Vold AM, Kreuter M (2021)
One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?
Thorax (in press)
DOI 10.1136/thoraxjnl-2021-217811, PubMed 34446525

Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O (2021)
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
ERJ Open Res, 7 (1)
DOI 10.1183/23120541.00235-2020, PubMed 33644224

Hoffmann-Vold AM, Volkmann ER (2021)
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
J. Scleroderma Relat. Disord., 6 (1), 2397198319891282-43
DOI 10.1177/2397198319891282

Holme SS, Kilian K, Eggesbø HB, Moen JM, Molberg Ø (2021)
Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis
Arthritis Res Ther, 23 (1), 18
DOI 10.1186/s13075-020-02401-x, PubMed 33430923

Hu Y, Rojahn AE, Flatø B (2021)
Multiorgan inflammatorisk syndrom hos barn og ungdom etter SARS-CoV-2-infeksjon
Tidsskr Nor Laegeforen, 141 (2021-14)
DOI 10.4045/tidsskr.20.1040, PubMed 34641663

Iudici M, Jarlborg M, Lauper K, Müller-Ladner U, Smith V, Allanore Y, Balbir-Gurman A, Doria A, Airò P, Walker UA, Riccieri V, Vonk MC, Gabrielli A, Hoffmann-Vold AM, Szücs G, Martin T, Distler O, Courvoisier DS, EUSTAR collaborators (2021)
Representativeness of Systemic Sclerosis Patients in Interventional Randomized Trials: an analysis of the EUSTAR database
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keab437, PubMed 33989387

Kreuter M, Hoffmann-Vold AM, Bendstrup E (2021)
Interstitial lung diseases: quo vadis?
Lancet Respir Med, 9 (10), 1084-1087
DOI 10.1016/S2213-2600(21)00403-3, PubMed 34499873

Marstein HS, Godang K, Flatø B, Sjaastad I, Bollerslev J, Sanner H (2021)
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study
Pediatr Rheumatol Online J, 19 (1), 56
DOI 10.1186/s12969-021-00543-z, PubMed 33902632

Nyborg GA, Molberg Ø (2021)
Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature
Semin Arthritis Rheum, 51 (5), 1033-1044
DOI 10.1016/j.semarthrit.2021.07.012, PubMed 34416625

Panagopoulos P, Goules A, Hoffmann-Vold AM, Matteson EL, Tzioufas A (2021)
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
Ther Adv Musculoskelet Dis, 13, 1759720X211037519
DOI 10.1177/1759720X211037519, PubMed 34471427

Reid S, Hagberg N, Sandling JK, Alexsson A, Pucholt P, Sjöwall C, Lerang K, Jönsen A, Gunnarsson I, Syvänen AC, Troldborg AM, Voss A, Bengtsson AA, Molberg Ø, Jacobsen S, Svenungsson E, Rönnblom L, Leonard D (2021)
Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus
Ann Rheum Dis, 80 (9), 1183-1189
DOI 10.1136/annrheumdis-2020-219727, PubMed 33766895

Reppe Moe S, Haukeland H, Molberg Ø, Lerang K (2021)
Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts
J Clin Med, 10 (19)
DOI 10.3390/jcm10194306, PubMed 34640322

Sande NK, Bøyesen P, Aga AB, Hammer HB, Flatø B, Roth J, Lilleby V (2021)
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis
RMD Open, 7 (2)
DOI 10.1136/rmdopen-2021-001581, PubMed 33883255

Solomon JJ, Swigris JJ, Kreuter M, Polke M, Aronson K, Hoffmann-Vold AM, Dellaripa PF (2021)
The Attitudes and Practices of Physicians Caring for Patients with Rheumatoid Arthritis-Interstitial Lung Disease: An International Survey
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keab552, PubMed 34260687

Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium, the ImmunoArray consortium, Meadows JRS, Rantapää-Dahlqvist S, Mandl T et al. (2021)
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome
Rheumatology (Oxford), 60 (2), 837-848
DOI 10.1093/rheumatology/keaa367, PubMed 32889544

Tollisen A, Flatø B, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A (2021)
Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis
Arthritis Care Res (Hoboken), 73 (2), 221-231
DOI 10.1002/acr.24113, PubMed 31758669

van Leeuwen NM, Boonstra M, Bakker JA, Grummels A, Jordan S, Liem S, Distler O, Hoffmann-Vold AM, Melsens K, Smith V, Truchetet ME, Scherer HU, Toes R, Huizinga TWJ, de Vries-Bouwstra JK (2021)
Anti-centromere antibody levels and isotypes and the development of systemic sclerosis
Arthritis Rheumatol (in press)
DOI 10.1002/art.41814, PubMed 34042326

Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J, Lin Q, Xie X, Zheng K, Zhang W, Du G, Zhang G, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE (2021)
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
Arthritis Res Ther, 23 (1), 212
DOI 10.1186/s13075-021-02586-9, PubMed 34391465

 
Page visits: 648198